Biograph
PrivateLast Round
Early Funding
Feb 27, 2025
Company Overview
Biograph operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was an Early Funding round in February 2025.
Biograph is a healthcare company that provides advanced diagnostic testing and preventive health services focused on longevity and early disease detection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical Imaging, Healthcare Analytics, Medical AI, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biograph Comparables
Compare Biograph with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Human Longevity | 87% | |
| Prenuvo | 86% | |
| Fountain Life | 86% |
For institutional investors. Book with your work email.
Biograph Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Biograph Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Early Funding |
| WndrCo | Early Funding |
| Vy Capital | Early Funding |
| Alpha Wave Global | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
New clinic opening in San Mateo, CA.
- Sep 30, 2025
Partnered with Caristo Diagnostics to study novel AI-based preventive cardiac marker.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 20, 2026
Biograph launches the Women's Health Program to provide women with a more comprehensive view of their health through female-specific history, personalized hormone testing, comprehensive risk assessment, and tailored nutrition and exercise in physician-led care.
- hiresAug 13, 2026
Biograph hires Meghan Musnicki for membership development and partnerships after an introduction through a mutual connection.
For institutional investors. Book with your work email.
Biograph Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biograph's valuation, stock price, and market status.
Is Biograph a public or private company?
Biograph is a private company.
What is the current stock price of Biograph?
Biograph is a private company, so its shares have no public market price. Caplight tracks Biograph's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biograph worth (valuation)?
Valuation information for Biograph is not publicly available.
Can I buy Biograph stock?
Biograph shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biograph's last funding round?
Biograph's most recent funding round was Early Funding on February 27, 2025.
Who are the main investors in Biograph?
Key investors in Biograph include Human Capital, WndrCo, Vy Capital, Alpha Wave Global.
Will Biograph IPO soon?
No public IPO plans have been announced for Biograph.
How can I track Biograph secondary market activity?
Caplight tracks bids, offers, and trades in Biograph's shares on secondary markets.